Milivoj Piletič

567 citations
10 papers · 461 indexed · 1 hit paper · h-index 6
Topics
Diabetes Treatment and Management (9 papers)Diabetes Management and Research (8 papers)Metabolism, Diabetes, and Cancer (5 papers)
Journals
SHILAP Revista de lepidopterologíaThe Lancet Diabetes & EndocrinologyDiabetes Obesity and Metabolism

In The Last Decade

Milivoj Piletič

10 papers receiving 447 citations

Hit Papers

Efficacy and safety of once-weekly semaglutide versus onc...20172026202020232017100200300

Peers

Milivoj Piletič
Comparison fields: 5 of 45
  • Endocrinology, Diabetes and Metabolism 435
  • Molecular Biology 256
  • Surgery 104
  • Pharmacology 86
  • Physiology 36
Replace Raymond de la Rosa with:
Raymond de la Rosa Denmark
Bob An United States
Tomoyuki Nishida Japan
Magnus F.G. Grøndahl Denmark
Ingrid Holst Denmark
Takanori Hyo Japan
Federico Pérez Manghi United States
Santiago Durán García Spain
Marian Benroubi Greece
Haysook Choi Canada
Milivoj Piletič relative to Raymond de la Rosa Denmark Raymond de la Rosa's profile →
Citations per field
00.5×1.5×
Raymond de la Rosa · 1×
Citations per year

Countries citing papers authored by Milivoj Piletič

Since Specialization
Citations

This map shows the geographic impact of Milivoj Piletič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milivoj Piletič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milivoj Piletič more than expected).

Fields of papers citing papers by Milivoj Piletič

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milivoj Piletič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milivoj Piletič. The network helps show where Milivoj Piletič may publish in the future.

Co-authorship network of co-authors of Milivoj Piletič

This figure shows the co-authorship network connecting the top 25 collaborators of Milivoj Piletič. A scholar is included among the top collaborators of Milivoj Piletič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milivoj Piletič. Milivoj Piletič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 3
3
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trialbreakdown →
340
4 38
5 2
6 2
7 11
8 5
9 14
10 45

About Milivoj Piletič

Milivoj Piletič is a scholar working on Endocrinology, Diabetes and Metabolism, Organizational Behavior and Human Resource Management and Molecular Biology, having authored 10 papers that have together received 461 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Diabetes Management and Research (8 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (435 citations), Pharmacology (86 citations) and Molecular Biology (256 citations). Milivoj Piletič has collaborated with scholars based in Denmark, United States and Canada. Frequent co-authors include Vanita R. Aroda, Bertrand Cariou, Ludger Rose, J. Hans DeVries, Stephen C. Bain, Everton Rowe, Mads Axelsen, М. В. Шестакова, Helena W. Rodbard and Sophie Jacqueminet. Their work appears in journals such as SHILAP Revista de lepidopterología, The Lancet Diabetes & Endocrinology and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026